Progressive loss of sensitivity to endothelium‐derived growth inhibitors expressed by human melanoma cells during disease progression
Abstract Tumor progression is frequently associated with changes in responsiveness of tumor cells to paracrine growth factors. A potential major source of such paracrine factors...